Extrapyramidal Signs and Cognitive Subdomains in Alzheimer Disease

被引:3
|
作者
Park, Jin Hong [1 ]
Myung, Woojae [1 ]
Choi, Junbae [1 ]
Kim, Sangha [1 ]
Chung, Jae Won [1 ]
Kang, Hyo Shin [3 ]
Na, Duk L. [2 ]
Kim, Seong Yoon [4 ]
Lee, Jae-Hong [5 ]
Han, Seol-Heui [6 ]
Choi, Seong Hye [7 ]
Kim, Sang Yun [8 ]
Kim, Doh Kwan [1 ]
机构
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Psychiat, 81 Irwon Ro, Seoul 135710, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul 135710, South Korea
[3] Samsung Biomed Res Inst, Clin Res Ctr, Seoul, South Korea
[4] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Psychiat, Seoul, South Korea
[5] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Neurol, Seoul, South Korea
[6] Konkuk Univ, Sch Med, Dept Neurol, Seoul, South Korea
[7] Inha Univ, Sch Med, Dept Neurol, Inchon, South Korea
[8] Seoul Natl Univ, Bundang Hosp, Dept Neurol, Seoul, South Korea
来源
基金
新加坡国家研究基金会;
关键词
Alzheimer disease; extrapyramidal signs; cognition; attention; visuospatial; WHITE-MATTER CHANGES; PARKINSONS-DISEASE; RATING-SCALE; MOTOR SIGNS; DEMENTIA; HYPERINTENSITIES; DIAGNOSIS; PROGRESSION; IMPAIRMENT; DEPRESSION;
D O I
10.1016/j.jagp.2016.02.051
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objective: Extrapyramidal signs (EPS), commonly observed in Alzheimer disease (AD), predict cognitive impairment and functional decline. This study investigated the association between EPS and five cognitive subdomains in a large number of participants with AD. Design: Cross-sectional analyses of the nationwide Clinical Research of Dementia of South Korea (CREDOS) study, 2005-2012. Setting: Multicenter clinical settings. Participants: 1,737 participants with AD drawn from the CREDOS study. Measurements: The EPS group was defined by the presence of at least one EPS based on neurologic examination. We assessed five cognitive subdomains: attention, language, visuospatial function, memory, and frontal/executive function using the Seoul Neuropsychological Screening Battery-Dementia version. The associations of EPS with each cognitive subdomain were analyzed with a multiple linear regression model after controlling for confounding factors: sex, age, years of education, severity of dementia (Clinical Dementia Rating Sum of Boxes), and white matter hyperintensities. Results: 164 AD participants (9.4%) had EPS. AD participants with EPS showed lower performance compared with those without EPS in two cognitive subdomains: attention and visuospatial function. The language, memory, and frontal/executive subdomains did not differ between the EPS-positive and the EPS-negative groups. In addition, we found a significant moderating relationship between EPS and deep white matter hyperintensities on visuospatial function score. Conclusions: EPS in AD are associated with severe cognitive impairment in attention and visuospatial function. Careful screening for EPS in patients with AD may assist in prediction of cognitive profile.
引用
收藏
页码:566 / 574
页数:9
相关论文
共 50 条
  • [1] Extrapyramidal signs and cognitive abilities in Alzheimer's disease
    Caligiuri, MP
    Peavy, G
    Galasko, DR
    [J]. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2001, 16 (09) : 907 - 911
  • [2] Pathological correlates of extrapyramidal signs in Alzheimer disease
    Liu, Y
    Stern, Y
    Chun, M
    Jacobs, D
    Goldman, JE
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1996, 55 (05): : 18 - 18
  • [3] Pattern of extrapyramidal signs in Alzheimer’s disease
    Giuseppe Tosto
    Sarah E. Monsell
    Stephen E. Hawes
    Richard Mayeux
    [J]. Journal of Neurology, 2015, 262 : 2548 - 2556
  • [4] Extrapyramidal or pseudoextrapyramidal signs in Alzheimer's disease?
    Kurlan, R
    [J]. ANNALS OF NEUROLOGY, 1998, 44 (05) : 840 - 841
  • [5] Pattern of extrapyramidal signs in Alzheimer's disease
    Tosto, Giuseppe
    Monsell, Sarah E.
    Hawes, Stephen E.
    Mayeux, Richard
    [J]. JOURNAL OF NEUROLOGY, 2015, 262 (11) : 2548 - 2556
  • [6] Extrapyramidal signs in patients with probable Alzheimer disease
    Lopez, OL
    Wisnieski, SR
    Becker, JT
    Boller, F
    DeKosky, ST
    [J]. ARCHIVES OF NEUROLOGY, 1997, 54 (08) : 969 - 975
  • [7] The pathology of the substantia nigra in Alzheimer disease with extrapyramidal signs
    Burns, JM
    Galvin, JE
    Roe, CM
    Morris, JC
    McKeel, DW
    [J]. NEUROLOGY, 2005, 64 (08) : 1397 - 1403
  • [8] Pathological correlates of extrapyramidal signs in Alzheimer's disease
    Liu, Y
    Stern, Y
    Chun, MR
    Jacobs, DM
    Yau, P
    Goldman, JE
    [J]. ANNALS OF NEUROLOGY, 1997, 41 (03) : 368 - 374
  • [9] Extrapyramidal motor signs in clinically diagnosed Alzheimer disease
    Ellis, RJ
    Caligiuri, M
    Galasko, D
    Thal, LJ
    [J]. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1996, 10 (02): : 103 - 114
  • [10] Modeling the influence of extrapyramidal signs on the progression of Alzheimer disease
    Stern, Y
    Liu, XH
    Albert, M
    Brandt, J
    Jacobs, DM
    DelCastilloCastaneda, C
    Marder, K
    Bell, K
    Sano, M
    Bylsma, F
    [J]. ARCHIVES OF NEUROLOGY, 1996, 53 (11) : 1121 - 1126